Status:

COMPLETED

Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project

Lead Sponsor:

Rutgers, The State University of New Jersey

Collaborating Sponsors:

Colorado Department of Public Health and Environment

University of New Mexico

Conditions:

Breast Cancer

Ovarian Cancer

Eligibility:

FEMALE

21+ years

Phase:

NA

Brief Summary

GRACE is a randomized 3-arm trial to determine the comparative effectiveness of two remote cancer communication interventions: 1) a targeted generic print (TP) or 2) a tailored telephone-based counsel...

Detailed Description

There is increasing evidence that activated and engaged patients who are equipped with necessary skills and information are more likely to follow through with recommended care and have better health o...

Eligibility Criteria

Inclusion

  • Breast Cancer
  • Hispanic or non-Hispanic
  • Female
  • 21 years of age or older
  • English-speaking
  • Breast cancer history
  • breast cancer at the age of 50 or younger OR
  • triple-negative breast cancer OR
  • two or more primary breast cancers
  • Ovarian Cancer
  • Hispanic or non-Hispanic
  • Female
  • 21 years of age or older
  • English-speaking
  • History of ovarian, fallopian, or peritoneal cancer diagnosed at any age

Exclusion

  • Have had prior genetic counseling or testing for hereditary breast and/or ovarian cancer

Key Trial Info

Start Date :

November 2 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 2 2022

Estimated Enrollment :

668 Patients enrolled

Trial Details

Trial ID

NCT03326713

Start Date

November 2 2017

End Date

June 2 2022

Last Update

May 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rutgers University

New Brunswick, New Jersey, United States, 08901